MAP3K8 antibody (pThr290)
Quick Overview for MAP3K8 antibody (pThr290) (ABIN2625110)
Target
See all MAP3K8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pThr290
-
Specificity
- Recognizes endogenous levels of TPL2 (pT290) protein.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic peptide encompassing a sequence within the central region of human TPL2 (pT290).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Aliquot to avoid freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Alternative Name
- MAP3K8 / TPL2
-
Background
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
Gene ID
- 1326
-
Pathways
- PI3K-Akt Signaling, TCR Signaling
Target
-